Clinical Trials Browser

Not yet recruiting × Hodgkin Disease × liposomal doxorubicin × Clear all

NCT07021989 2026-03-17

ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma

Phase 2 Not yet recruiting

Hodgkin Disease